Abstract
Current drug regulation in Korea is based on the Pharmaceutical Affairs Law, which has been revised 14 times. Toxicity guidelines are described in the Regulation for Evaluation on Safety and Efficacy of Drugs (Korea Food and Drug Administration Notification No. 1999-60, revised on December 22, 1999) and Guidelines for Toxicity Studies of Drugs (Korea Food and Drug Administration Notification No. 1999-61, revised on December 22, 1999). This paper describes the review process and toxicity guidelines for new drug approval in Korea.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
